California Stem Cell Performance Audit: Oversight Panel Postpones Action until Spring

Need for Improvement in Key Areas Cited in Audit

Nov 11, 2021

∙ Paid

Public discussion of recommended improvements in the performance of California’s stem cell program has been put off until sometime next year by the only state entity charged with financial oversight of the $12 billion program.

The action was taken Wednesday by Betty Yee, the top fiscal officer for the state of California and chair of the Citizens Financi…

Keep reading with a 7-day free trial

Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.